Perceptive Advisors’s Twist Bioscience TWST Stock Holding History

Perceptive Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79M	Sell	36,812 -113,188	-75%	-$7.37M	0.06%	96
2026 Q1	$7.13M	Buy	+150,000	New	+$6.73M	0.14%	72
2020 Q4	–	Sell	-112,756	Closed	-$8.57M	–	153
2020 Q3	$8.57M	Sell	112,756 -160,000	-59%	-$9.96M	0.13%	93
2020 Q2	$12.4M	Sell	272,756 -49,600	-15%	-$1.78M	0.2%	76
2020 Q1	$10.4M	Buy	322,356 +106,500	+49%	+$2.86M	0.27%	60
2019 Q4	$4.53M	Buy	215,856 +70,000	+48%	+$1.64M	0.09%	80
2019 Q3	$3.48M	Buy	145,856 +35,000	+32%	+$1.02M	0.09%	78
2019 Q2	$3.22M	Buy	+110,856	New	+$2.93M	0.07%	82

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Perceptive Advisors's TWST Position: Q2 2026 in Review

Perceptive Advisors reduced its Twist Bioscience (TWST) stake by 75% in Q2 2026, selling an estimated $7.37M and leaving 36,812 shares worth $3.79M. The position accounts for 0.06% of the portfolio, ranked #96.

Perceptive Advisors first reported a position in TWST in Q2 2019 and has held it in 8 quarters since. The position peaked at $12.4M in Q2 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Perceptive Advisors held 36,812 shares of Twist Bioscience worth $3.79M as of Q2 2026.
Perceptive Advisors sold 113,188 Twist Bioscience shares in Q2 2026, an estimated $7.37M.
Twist Bioscience made up 0.06% of Perceptive Advisors's portfolio in Q2 2026, its #96 holding.
Perceptive Advisors first reported a position in Twist Bioscience in Q2 2019 and has held it in 8 quarters since.
Perceptive Advisors's Twist Bioscience position peaked at $12.4M in Q2 2020.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.